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Background: The high burden of diabetes for healthcare costs and their impact on quality of life and management
of the disease have triggered the design and introduction of disease management programmes (DMPs) in many
countries. The extent to which diabetes patients vary with regard to their healthcare utilisation and costs is largely
unknown and could impact on the design of DMPs. The objectives of this study are to develop profiles based on
both the diabetes-related healthcare utilisation and total healthcare utilisation in primary care, to investigate which
patient and disease characteristics determine ‘membership’ of each profile, and to investigate the association
between these profiles.
Methods: Data were used from electronic medical records of 6721 known type II diabetes patients listed in 48
Dutch general practices. Latent Class Analyses were conducted to identify profiles of healthcare and regression
analyses were used to analyse the characteristics of the profiles.
Results: For both diabetes-related healthcare utilisation and total healthcare utilisation three profiles could be
distinguished: for the diabetes-related healthcare utilisation these were characterised as ‘high utilisation and frequent
home visits’ (n=393), ‘low utilisation, GP only’ (n=3231) and ‘high utilisation, GP and nurse’ (n=3097). Profiles differed
with respect to the patients’ age and type of medication; the oldest patients using insulin were dominant in the
‘high utilisation, GP and nurse’ profile. High total healthcare utilisation was not associated with high diabetes-related
healthcare utilisation.
Conclusions: Healthcare utilisation of diabetes patients is heterogeneous. This challenges the development of
distinguishable DMPs.
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The number of people with type II diabetes mellitus is in-
creasing [1]. Due to the high burden of diabetes in particu-
lar and chronic diseases in general for healthcare costs and
their impact on quality of life, management of these dis-
eases has become an important issue in health policy in
many countries [2]. This has triggered the design and
introduction of disease management programmes (DMPs)* Correspondence: c.vandijk@nivel.nl
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reproduction in any medium, provided the orfor type II diabetes mellitus in particular. According to the
Disease Management Association of America (DMAA)
disease management is defined as a system of coordinated
healthcare interventions and communications for popula-
tions with conditions in which patients’ self-care efforts
are significant. Disease management supports the phys-
ician or practitioner/patient relationship and plan of care,
emphasizes prevention of exacerbations and complica-
tions through the use of evidence-based practice guide-
lines and patient empowerment, and evaluates clinical,
humanistic, and economic outcomes on an ongoing basis
with the goal of improving overall health [3]. DMPs are
expected to be a solution for the inadequate coordinationl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and increasing costs for chronic illnesses [4]. However, lit-
erature on the design and effects on health and disease
outcomes is inconclusive and research currently focuses
mainly on refining these issues, such as defining the opti-
mal patient group per programme [5,6].
Remuneration of DMPs differs between European
countries: a yearly price for total care for a chronic dis-
ease (e.g. Denmark, UK, the Netherlands), a financial
bonus for general practitioners (GPs) per patient that is
included in a DMP (e.g. France), dedication of one per-
cent of the total health care budget and refunding add-
itional services for DMP-patients (e.g. Germany) [7]. A
position paper showed that providing financial incentives
to relevant stakeholders is important for facilitating suc-
cessful implementation of DMPs [4]. Stakeholders may
be reluctant to invest in better chronic care if their
investments are not accompanied by better payment, or
at least equal compensation [8]. Setting the incentives cor-
rectly will encourage healthcare providers to efficiently
provide healthcare services. In the case of DMPs, varying
healthcare demands between and within patients over
time might make it problematic to design a good financial
compensation system for DMPs. If physicians are paid an
equal amount per patient, they might be reluctant to in-
clude patients with a high healthcare demand and conse-
quently risk of financial losses or risk of under-treatment
[9]. On the other hand, a fee-for-service remuneration sys-
tem might provide the incentive for physicians to increase
the number of services, with a risk for increased costs
and over-treatment [9,10]. Incorporating possible het-
erogeneity of patients’ healthcare demands in the design
of DMPs and remuneration of professionals might be a
solution to this problem. However, to what extent dia-
betes patients vary with regard to their healthcare util-
isation and costs is largely unknown. El Fakiri et al.
distinguished healthcare utilisation patterns for diabetes
patients in the Netherlands [11]. However, these pat-
terns were based on the total healthcare utilisation of
diabetes patients and did not distinguish between type I
and type II diabetes patients, although it is known that
healthcare utilisation of type I and type II diabetes
patients is different [11-13]. Moreover, DMPs have
been focusing mainly on just one disease and not on
multiple diseases. Most diabetes patients, however, also
suffer from other chronic diseases. Sixty percent of dia-
betes type II patients have at least one other chronic
disease and twelve percent of the patients even have
three or more other chronic conditions [14]. Although
it might be more realistic to incorporate all utilised
healthcare instead of diabetes-related healthcare util-
isation only in DMPs, we do not know whether dia-
betes patients with a high healthcare demand related
to diabetes also have a higher demand for healthcare ingeneral and, if so, whether this is equally true for all
diabetes patients.
The objective of this study was therefore to empirically
develop profiles of healthcare use of type II diabetes
patients based on both the total healthcare utilisation
and diabetes-related healthcare utilisation in primary
care; to determine which patient and disease characteris-
tics determine the ‘membership’ of each profile; and to
assess the association between profiles of total health-
care utilisation and diabetes-related utilisation. Such em-
pirically derived profiles may be useful when designing
DMPs and planning remuneration of professionals.
Methods
Study design
For the purpose of this retrospective study, primary care
utilisation of known diabetes patients was assessed in
2008 by developing profiles of diabetes-related health-
care utilisation and of total health-care utilisation separ-
ately. Data from the Netherlands Information Network
of General Practice (LINH) were used, which is a repre-
sentative sample of GP-practices in the Netherlands that
provide routinely recorded data from their electronic
medical records (EMRs) of all patients listed in their
practice. The Dutch healthcare system is very useful for
analysing longitudinal data. All Dutch inhabitants are
obligatory listed in a general practice and the GP acts as
gatekeeper for specialized health care. Therefore, the
EMR kept by the GP is the most complete record. The
LINH-database holds longitudinal data on morbidity,
drug prescriptions and referrals of approximately 90 GP-
practices and 350,000 listed patients [15]. The network
is a dynamic pool of practices, with each year some
minor changes in the composition of practices. Diagno-
ses are coded by the GPs using the International Classifi-
cation of Primary Care (ICPC) [16]. LINH is registered
with the Dutch Data Protection Authority; data are
handled according to the data protection guidelines of
the authority. According to the Dutch legislation, ethical
approval is not required for observational studies.
For our analyses, we used data from practices that
a) participated in both 2007 (for determining known
diabetes patients) and 2008 and b) provided recorded
year-round data for consultations, prescriptions, and
morbidity and referral records in 2008.
Patients were selected for this study if 1) they had
consulted their GP for type II diabetes at least once in
2007 and 2) were registered with the practice during
the whole year in 2008 and 3) were 18 or older. Type
II diabetes patients were selected on the basis of a
recorded ICPC-code T90. GPs participating in LINH do
generally not record on ICPC sub codes (T90.1 or
T90.2), and therefore we could not distinguish between
type I and type II diabetes patients on the basis of
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betes patients were excluded on the basis of having
received a prescription of insulin (ATC-code A10A),
but not any oral anti-diabetic medication (ATC-code
A10B) [14,17]. In total, data of 48 GP-practices and
6,721 type II diabetes patients were included. Reasons
for exclusion were 1) incomplete data on consultations
(16% of practices), 2) incomplete data on prescriptions
(28%) and/or 3) incomplete data on referrals (44%).
Overall, these GP-practices were representative of the
Dutch GP-practices with respect to degree of urbanisa-
tion and region, but not with respect to practice type
(overrepresentation of group practices or health centres,
underrepresentation of single handed practices).
Healthcare utilisation in primary care
Healthcare utilisation of subjects consisted of contacts
with general practice, drug prescriptions and referrals to
allied healthcare: primary healthcare and medication.
Healthcare utilisation was regarded as diabetes-related, if
the care provided was mentioned in the multidisciplinary
healthcare standard of the Dutch Diabetes Federation
(NDF: “Nederlandse Diabetes Federatie”) [18]. We only
took into account healthcare utilisation for which an
ICPC code was recorded by the GP. Additional file 1
shows the definition of diabetes related healthcare for
known type II diabetes patients with the corresponding
ICPC-codes.
Contacts in general practice were derived from claims
data in the EMR in which a distinction was made be-
tween consultations in the practice, home visits and tele-
phone consultations with GPs and primary care nurses.
The numbers of consultations, home visits and tele-
phone consultations with both GPs and primary care
nurses separately, were included in the analyses.
Drug prescriptions were coded using the ATC classifica-
tion system. Prescriptions mentioned in de NDF-guideline
(see Additional file 1) as well as prescriptions related to the
diabetes-related health problems were included in the ana-
lyses of diabetes-related profiles. A list of included drug
prescriptions is provided in Additional file 2. The number
of different drug prescriptions based on ATC codes at the
4 digit level was included in the analyses. If a prescription
could be captured with an ATC code at the 5 digit level,
the ATC code at the 5 digit level was included.
Healthcare utilisation of patients with allied healthcare
providers was estimated on the basis of GP referrals.
Referrals for diabetes-related health problems to a
physiotherapist or exercise therapist, dietician and po-
diatrist were included in the analyses.
Patient and disease characteristics
Patient and disease characteristics included in this study
were age (categorised), gender, urbanisation (categorised),diabetes medication type (no treatment, oral treatment or
oral treatment and insulin) and comorbidity; all data were
derived from the EMR. Comorbidity was divided into sev-
eral categories of related and unrelated comorbidity accord-
ing to Struijs et al. (2006) [19]. The following comorbid
diseases were regarded as diabetes-related: (with ICPC-
codes): heart diseases (K74-K76), stroke (K90), retinopathy
(F83), nephropathy (U99) and diabetic foot (K99.06 and
N94; deviated from Struijs et al.). Non-related comorbidity
included depression (P76), lung diseases (R91, R95, and
R96), musculoskeletal diseases (L01-L03, L08, L13, L15,
L84, L86, and L89-91), neurological diseases (N86-N88)
and cancer (B74, D74, D75, D77, R84, S77, X76, Y77).
Statistical analyses
To analyse the different profiles, Latent Class Analyses
(LCA) were performed to identify distinct classes of
patients with specific combinations of healthcare utilisa-
tion. LCA is a type of cluster analysis used to group
patients into k number of unique (otherwise unobserved)
categories, where, within each category patients are most
similar to each other regarding their healthcare utilisation,
and between the categories patients are most different
[20-22]. To find the optimal number of categories, a 2–6
class solution was modelled and output was assessed and
compared according to a stepwise approach described
elsewhere [20,22]. To determine the final solution several
model fit indicators were used [23]. The Bayesian Infor-
mation Criterion (BIC) (where a lower BIC indicates a
better fit) and posterior probabilities (where probabilities
close to 1 indicates a better classification and posterior
probabilities at least 0.8 are advised [24,25]) were used as
model fit indicators. Also, we assessed the usefulness and
clinical interpretation of each solution. The usefulness
was assessed by considering the solutions based on the
number of people in each class (hereby rejecting solu-
tions with small groups: minimum N = 200). Mplus was
used to perform LCA because within Mplus, LCA can
adequately cluster a combination of both categorical
(also binary variables) and count data [26]. LCA was
conducted for both diabetes-related healthcare utili-
sation and total healthcare utilisation separately. Each
profile was given a label resembling their healthcare
utilization. Subsequently, a predictive model was made
using multilevel multinomial regression analyses (patients
nested in practices) for the diabetes-related healthcare
utilisation profiles. In this analysis, it was assessed whether
patient and disease characteristics were associated to pro-
file membership. Analyses were performed using STATA,
Mplus and MLwiN.
Results
For both the diabetes-related primary healthcare and
total primary healthcare, a three-class solution was found
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in the statistical analyses section above (BIC: 102255,
posterior probabilities 0.969, 0.941 and 0.963 respectively
and BIC: 148819 and posterior probabilities 0.913, 0.949
and 0.917 respectively). Table 1 presents the descriptive
information of the profiles regarding healthcare utilisa-
tion. Table 2 describes the diabetes-related healthcare-
profiles in terms of patient and disease characteristics.Profiles of diabetes-related primary healthcare utilisation
In the first three columns of Table 1 the descriptive infor-
mation of the profiles regarding diabetes-related health-
care is presented. The first profile ‘high utilisation and
frequent home visits’ was mainly characterised by a high
number of home visits and telephone consultations by
both GPs and primary care nurses. Consultations in the
practice were less common for diabetes patients in this
profile. The second profile ‘low utilisation, GP only’ was
characterised by a relatively low number of consultations.
Patients in profile 3 ‘high utilisation, GP and nurse’ were
characterised by a high number of consultations in the
practice, especially frequent consultations with primary
care nurses. Diabetes patients in profile ‘high utilisation
and frequent home visits’ had on average 4.7 face-to-face
contacts related to diabetes with GPs and/or primary care
nurses, patients in profile ‘low utilisation, GP only’ 1.9 and
diabetes patients in profile ‘high utilisation, GP and nurse’
had 5.8 contacts.Table 1 Description of profiles of diabetes-related and total p
Diabetes-related primary healthcare
Profile 1 Profile 2 Prof
‘high utilisation and
frequent home visits’
(n=393)
‘low utilisation,
GP only’
(n=3231)
‘high
GP a
(n=3
mean (95% CI) mean (95% CI) mean
Number per year
GP contacts 0.45 (0.34-0.59) 1.65 (1.30-2.10) 1.59
GP home visits 1.08 (0.88-1.32) 0.19 (0.14-0.27) 0.05
GP telephone consultation 0.95 (0.70-1.30) 0.28 (0.21-0.38) 0.30
Primary care nurse contacts 0.41 (0.27-0.63) 0.09 (0.04-0.21) 3.48
Primary care nurse home visits 2.71 (2.23-3.29) 0.00 (0.00-0.01) 0.69
Primary care nurse telephone
consultation
1.99 (1.13-3.50) 0.01 (0.00-0.03) 0.68
Number of different prescription
(ATC4-level)
4.42 (4.14-4.69) 3.28 (3.13-3.43) 3.68
Referral to (%)
Dietician 1.6% 1.0% 1.3%
Physiotherapist 4.3% 3.3% 4.9%
Podiatrist 1.5% 0.3% 1.4%Table 2 shows the comparison of the three profiles
with regard to patient and disease characteristics; Table 3
shows the results of the multinomial logistic regression
analysis. Clearly, diabetes patients in profile 1 were sig-
nificantly older, mostly female, more of them had had a
stroke, and had a significantly higher prescription rate of
both oral medication only and of the combination of
oral and insulin medication. Patients in profile 2 and
profile 3 were difficult to distinguish; the only clear dif-
ference was the age range and medication usage, with
the youngest patients and patients with no diabetes
medication classified in profile 2.
Although corrected for patient and disease characteris-
tics, large practice variance still existed with regards to
profile membership. For example, for 13 practices all
patients were assigned to profile 2, and for one practice
all patients were assigned to profile 3. General practices
with patients assigned in profile 2 had less often a pri-
mary care nurse working in the practice, were more
often single handed practices and less often group prac-
tices compared to general practices with more variation
in patients’ profiles.Profiles of total primary healthcare utilisation
The last three columns of Table 1 show the descriptive
information of the profiles including total primary
healthcare. The first profile ‘low utilisation, GP only’ was
characterised by GP-consultations in the practice only inrimary healthcare utilisation of diabetes type II patients
Total primary healthcare
ile 3 Profile 1 Profile 2 Profile 3
utilisation,
nd nurse’
097)
‘low utilisation,
GP only’
(n =2669)
‘medium-high
utilisation,
GP and nurse”
(n=2929)
‘high utilisation’
(n=1123)
(95% CI) mean (95% CI) mean (95% CI) mean (95% CI)
(1.27-1.98) 4.38 (3.84-4.99) 4.34 (3.65-5.17) 5.67 (4.37-7.36)
(0.02-0.10) 0.15 (0.09-0.26) 0.09 (0.06-0.14) 3.95 (3.07-5.07)
(0.24-0.39) 0.81 (0.58-1.11) 0.86 (0.69-1.08) 4.15 (3.55-4.85)
(3.01-4.03) 0.08 (0.04-0.20) 3.75 (3.33-4.23) 1.15 (0.58-2.31)
(0.50-0.94) 0.00 (0.00-0.01) 0.02 (0.01-0.04) 1.27 (0.83-1.94)
(0.47-0.98) 0.01 (0.00-0.03) 0.60 (0.40-0.91) 1.26 (0.72-2.23)
(3.52-3.84) 6.70 (6.12-7.28) 7.23 (6.62-7.84) 13.28 (12.65-
13.91)
1.6% 2.8% 2.5%
5.7% 8.6% 13.7%
4.2% 2.9% 2.6%
Table 2 Patient and disease characteristics of profiles of diabetes-related primary healthcare of diabetes type II
patients
Diabetes-related primary healthcare
Profile 1 Profile 2 Profile 3
‘high utilisation and ‘low utilisation, GP only’ ‘high utilisation,
frequent home (n=3231) GP and nurse’
visits’ (n=3097)
(n=393)
Gender (% female) 73.5 50.8 48.0
Age
18-34 0.3 1.7 0.5
35-44 0.8 5.9 3.7
45-54 1.0 14.3 13.2
55-64 3.3 26.3 29.4
65-74 16.8 26.1 30.6
75 and older 77.9 25.7 22.5
Urbanisation
2500 or more addresses per square km 27.0 26.5 13.2
1500-2499 addresses per square km 20.9 27.3 31.8
1000-1499 addresses per square km 20.9 21.8 13.3
500-999 addresses per square km 14.5 11.3 15.7
<500 addresses per square km 16.8 13.1 26.0
Main medication
No medication 16.0 32.3 25.1
Oral medication only 61.3 54.6 61.6
Oral medication and insulin 22.7 13.1 13.3
Related comorbidity
Heart diseases 21.4 10.5 15.2
Stroke 10.7 3.3 3.2
Retinopathy 1.0 0.5 0.6
Nephropathy 6.6 1.9 2.6
Diabetic foot 2.8 2.1 1.8
Non-related comorbidity
Depression 8.7 3.9 4.3
Lung diseases 18.1 9.0 12.0
Musculoskeletal diseases 36.4 27.0 28.0
Neurological diseases 2.0 1.2 1.1
Cancer 8.1 3.7 3.4
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drug prescriptions and referrals, although 4.2% of the
patients were referred to a podiatrist. The second profile
‘medium-high utilisation, GP and nurse’ was also charac-
terised by a high number of GP-consultations in the
practice, and by a higher number of consultations with a
primary care nurse in the practice. Patients in profile 3
‘high utilisation’ were particularly characterised by con-
tacts with a GP in practice and home visits by both GP
and nurse. Moreover, patients in this profile were char-
acterised by a high prescription rate and referrals tophysiotherapists. Diabetes patients in profile ‘low utilisa-
tion, GP only’ had on average 4.6 face-to-face contacts
with GPs and/or primary care nurses, patients in profile
‘consultation by GP and nurse’ 8.2 and diabetes patient
in the profile ‘high utilisation’ 12.0 contacts.
Comparing membership of profiles of diabetes-related
primary care with membership of profiles of total primary
healthcare utilisation
Table 4 shows the cross tabulation between the diabetes-
related primary care profiles and total primary healthcare
Table 3 Results of multilevel multinomial logistic regression analysis predicting cluster membership
Diabetes-related healthcare
Profile 1 ‘high utilisation and
frequent home visits’
Profile 3 ‘high utilisation,
GP and nurse’
Profile 1 ‘high utilisation and
frequent home visits’
(Profile 2 ‘low utilisation, GP
only’= reference group)
(Profile 2 ‘low utilisation, GP
only’= reference group)
(Profile 3 ‘high utilisation, GP
and nurse’= reference group)
Patient and disease characteristics Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Gender (reference male) 1.80 (1.38-2.34) 0.92 (0.83-1.02) 2.27 (1.76-2.93)
Age (reference 18–44)
45-54 0.43 (0.09-1.92) 1.46 (1.12-1.90) 0.35 (0.07-1.72)
55-64 0.71 (0.21-2.41) 1.64 (1.29-2.10) 0.48 (0.13-1.82)
65-74 3.24 (1.08-9.69) 1.74 (1.36-2.22) 2.22 (0.67-7.39)
75 and older 16.20 (5.55-47.27) 1.26 (0.98-1.62) 15.47 (4.76-50.27)
Urbanisation (reference: 2500 or more addresses
per square km)
1500-2499 addresses per square km 0.61 (0.38-0.99) 1.19 (0.94-1.52) 0.57 (0.36-0.90)
1000-1499 addresses per square km 0.69 (0.40-1.21) 1.11 (0.83-1.48) 0.65 (0.38-1.10)
500-999 addresses per square km 0.58 (0.30-1.12) 1.14 (0.82-1.60) 0.53 (0.28-1.00)
<500 addresses per square km 0.66 (0.34-1.29) 1.17 (0.80-1.72) 0.60 (0.32-1.15)
Main medication form (reference: no medication)
Oral medication only 2.16 (1.58-2.96) 1.61 (1.43-1.82) 1.53 (1.13-2.06)
Oral medication and insulin 3.46 (2.35-5.10) 1.15 (0.96-1.37) 3.24 (2.25-4.67)
Related comorbidity
Heart diseases 1.04 (0.76-1.44) 0.99 (0.85-1.15) 1.14 (0.85-1.53)
Stroke 1.90 (1.25-2.89) 0.76 (0.57-1.01) 2.92 (2.00-4.27)
Retinopathy 1.28 (0.37-4.50) 1.43 (0.73-2.82) 0.55 (0.14-2.18)
Nephropathy 1.34 (0.78-2.28) 0.88 (0.62-1.24) 1.65 (1.00-2.70)
Diabetic foot 1.01 (0.48-2.11) 0.88 (0.61-1.27) 1.21 (0.62-2.36)
Non-related comorbidity
Depression 1.50 (0.96-2.35) 1.03 (0.80-1.32) 1.72 (1.15-2.56)
Lung diseases 1.44 (1.04-1.98) 1.00 (0.85-1.18) 1.40 (1.03-1.89)
Musculoskeletal diseases 1.20 (0.94-1.55) 1.05 (0.94-1.17) 1.20 (0.95-1.51)
Neurological diseases 1.06 (0.45-2.49) 0.75 (0.46-1.22) 1.89 (0.91-3.91)
Cancer 1.34 (0.84-2.14) 0.80 (0.61-1.06) 1.84 (1.20-2.82)
Table 4 Cross tabulation of profiles of diabetes-related and total primary healthcare utilisation of diabetes type II
patients
Diabetes-related primary healthcare
Total primary healthcare Profile 1 ‘high utilisation and
frequent home visits’ (n=393)
Profile 2 ‘low utilisation,
GP only’ (n=3231)
Profile 3 ‘high utilisation,
GP and nurse’ (n=3097)
Profile 1 4 2661 4
‘low utilisation, GP only’ (n=2669)
Profile 2 3 130 2796
‘ medium-high utilisation, GP and nurse” (n=2929)
Profile 3 386 440 297
‘high utilisation’ (n= 1123)
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healthcare (profile 1) was associated with a low diabetes-
related healthcare utilisation (profile 2), whereas a high
total healthcare utilisation (profile 3) did not necessarily
imply a high healthcare utilisation profile for diabetes-
related primary healthcare. Comparing the two profiles
with high diabetes-related primary healthcare utilisation
(profile 1 and 3) for diabetes patients with the total pri-
mary healthcare profile ‘high utilisation’ showed that dia-
betes patients in the ‘high utilisation and frequent home
visits’ profile (n=386) were more often women and aged
75 year or older, and diabetes patients in the ‘high utilisa-
tion, GP and nurse’ (n=297) more often had diabetes
related comorbidity (heart disease and stroke) and unre-
lated comorbidity (lung- and musculoskeletal diseases).
Discussion
The purpose of this study was to develop profiles based
on both total and diabetes-related primary healthcare
utilisation and to investigate the association between
profiles of total healthcare utilisation and diabetes-
related utilisation. For both diabetes and total primary
healthcare utilisation, three clearly distinct profiles were
found with regard to the type of contacts and type of
healthcare provider (GP or primary care nurse). Patient
and disease characteristics were, however, not always
associated with the membership of each profile. Age and
type of medication – no medication, oral medication or
oral medication and insulin – were the strongest indica-
tors for diabetes-related primary healthcare profiles. Dia-
betes patients with a high total healthcare utilisation
(profile ‘high utilisation’), were not always patients with
a high utilisation pattern for diabetes (‘high utilisation,
GP and nurse’), whereas having a low total healthcare
utilisation profiles was associated with a low contact rate
for diabetes.
Profiles of diabetes-related primary care utilisation
According to the guidelines, type II diabetes patients
under supervision of GPs should have four regular
check-ups within the practice per year [18]. Of our three
diabetes-related primary healthcare utilisation profiles,
only the patients in profile ‘low utilisation, GP only’ had
on average less than the recommended four contacts for
diabetes-related issues. Interestingly, this profile repre-
sented almost half of the type II diabetes population in
general practice. Principal treatment in secondary care
(by an internist – in the Netherlands internists are not
seen as primary care specialists) could explain the low
number of contacts in primary care for part of this sub-
group, but we do not have information available in our
dataset to confirm this. However, from a report pub-
lished by the National Institute for Public Health and
the Environment (RIVM), it is known that only a smallnumber of type II diabetes patients is under treatment
solely by an internist [27], thereby possibly not providing
a full explanation for our findings. Thus, part of the type
II diabetes patients did not have the recommended four
contacts annually for diabetes-related health problems.
In general, the patients in the profile with low frequency
of contacts are the youngest in the sample, and also
show the lowest prevalence of co-morbidity. This might
coincide with well-controlled diabetes, indicating a less-
frequent need for primary care consultations [28]. In this
respect, our findings showing that patients from a quar-
ter of the practices were all assigned to the 'low utilisa-
tion, GP only' profile, are notable. It might be that these
practices do not provide adequate care to type II dia-
betes patients, which may be explained by unavailability
of primary care nurses.
We showed that diabetes-related primary healthcare
utilisation is heterogeneous. Only one previous study
has researched this heterogeneous presentation also
[11]. This study, conducted in a much smaller sample of
Dutch diabetes patients (around 400 patients), included
both type I and type II diabetes patients and total care
utilised in both primary and secondary care, found four
distinct profiles of healthcare utilisation. Although diffi-
cult to compare due to methodological issues, our pro-
files point to a fairly similar picture; for example, we
also find a large subgroup of patients with low health-
care utilisation.
Determinants of diabetes-related primary healthcare
profile membership
Diabetes-related primary healthcare profiles could only
partly be explained by patient and disease characteristics.
Age and use of oral medication and insulin were the stron-
gest predictors for membership in a diabetes-related pri-
mary healthcare profile with high utilisation. In agreement
with our study, El Fakiri et al. also found, except for the
type of diabetes, little effect of possible predictors for the
different healthcare profiles. However, this study investi-
gated other predictors than we did [11]. They did show
that the patients classified into the profile with the high-
est number of contacts in general practice more often
had comorbidity, which was not consistently found in
our study. However, this difference can be explained by
the fact that our membership of the profiles was deter-
mined on diabetes-related primary healthcare utilisation
only. These results illustrate the difficulty of predicting
healthcare utilisation for diabetes patients. With the con-
sequence that it is also problematic to develop different
DMP for diabetes type II based on patient and disease
characteristics, since it does not resemble the healthcare
utilisation and therefore costs. In conclusion, these results
do not assist health planners in allocating diabetes type II
patients in different DMPs. However, differentiations in
van Dijk et al. BMC Health Services Research 2013, 13:7 Page 8 of 9
http://www.biomedcentral.com/1472-6963/13/7the remuneration system for patients with differing health-
care demands might also lead to an unnecessary com-
plexity in the design of such DMPs, coinciding with an
increase in administrative costs.
Association between diabetes-related and total primary
healthcare utilisation
Our study showed that a high total primary healthcare
utilisation profile was not generally associated with a
high diabetes-related primary healthcare utilisation pro-
file. Both age and the existence of related and unrelated
comorbidity were determinants for having both a higher
total and diabetes-related primary healthcare utilisation
profile. This is in accordance with previous research
that showed that both diabetes-related and diabetes-
unrelated comorbidity increased the use of medical care
in diabetes patients [19]. A recent review also showed a
positive association between multiple chronic condi-
tions and healthcare utilisation and expenditure [29].
These results indicate that total primary healthcare util-
isation is not a good indicator for disease specific
healthcare utilisation. When incorporating total utilised
healthcare instead of diabetes-related healthcare utilisa-
tion only in a DMP, specific attention should be paid to
the role of age and comorbidity, in particular as only
these patient characteristics predict high healthcare util-
isation for both total and diabetes-related care.
Strengths and limitations
The empirical derivation of profiles of healthcare utilisa-
tion of type II diabetes patients as opposed to self-defined
profiles provides new insights in healthcare utilisation and
demands of type II diabetes patients. A number of points
should be considered in our study. First, not all GPs’
actions were recorded in a structured way in their EMR
and could for that reason not be incorporated in our
analyses. We chose to include only the information that
was recorded in a concise and structured way by all
GPs. This meant that we unfortunately were unable to
include information about the exact content of the con-
sultations in general practice and do not know whether
for example lifestyle advice was given, nor were struc-
tured clinical outcome data available (e.g. glycated
haemoglobin level or blood pressure). This then makes
it impossible to make inferences about the effect of the
different primary healthcare utilisation profiles on pa-
tient outcomes. This should be addressed in future
research. Second, no referral to a physiotherapist is
needed since 2006 and therefore the number of patients
visiting a physiotherapist was underestimated. Research
shows that mostly patients with acute problems (instead
of chronic problems) visit a physical therapist on their
own initiative, which is not often the case with diabetes
patients [30]. In some practices no primary care nursewas working in the practice, and therefore these patients
may not be assigned to profiles which are largely
described by contacts with primary care nurses. Add-
itional analyses (available upon request by the first
authors) limited to practices with a primary care nurse
showed similar effects of determinants of diabetes-
related primary healthcare profile membership, al-
though the profile ‘high utilisation, GP and nurse’ in
comparison to the profile ‘low utilisation, GP only’
showed slightly underestimated effects of the main
medication type for diabetes compared to the model
with all practices. In addition, healthcare utilisation as
presented in this study does not reflect the ideal or
needed level of healthcare.Implications of the findings
DMPs are expected to be the solution for the inadequate
coordination of care, variation in quality of care and in-
creasing costs for illnesses [4]. The design of such standar-
dised programmes ultimately requires a homogeneous
patient population or in case of a heterogeneous popula-
tion at least one that is easily explained by clear patient
and disease characteristics. Unexplained heterogeneity in
healthcare demands of these patients, therefore, means
that a standardised programme might be insufficient or
inadequate for some patients. Moreover, a heterogeneous
patient population with diverse healthcare demands might
cause physicians to be reluctant in the inclusion of
patients with high healthcare demands. The issue of mul-
timorbidity is also predominant in type II diabetes
patients. This results in the fact that a large part of the
healthcare utilisation of these patients might not be
included in diabetes DMPs if these DMPs would focus ex-
clusively on diabetes neglecting other existing health pro-
blems [14]. With a non-explained heterogeneous diabetes
type II population and large non-diabetes-related primary
healthcare utilisation, health planners might consider put-
ting more emphasis on case management instead of dis-
ease management.Conclusions
In conclusion, we have shown that primary healthcare
utilisation of diabetes patients is heterogeneous, which
could be captured in three distinct profiles of diabetes-
related and total healthcare utilisation. The diabetes-
related profiles were only partly explained by patient and
disease characteristics, posing difficulties for the future de-
velopment of distinguishable disease management pro-
grammes. Further, we have shown that total primary
healthcare utilisation is not a good indicator for diabetes-
related primary healthcare utilisation for diabetes patients.
This fact should also be taken into account in the remu-
neration system of DMPs.
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